Functional characterization of a cytosolic malic enzyme crucial for pyridine nucleotide homeostasis, redox balance, and virulence in Leishmania major
This study identifies and characterizes LmME2 as the first cytosolic malic enzyme in *Leishmania major*, demonstrating that its loss disrupts pyridine nucleotide homeostasis and redox balance, thereby impairing parasite survival and virulence and highlighting it as a promising drug target.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Imagine a microscopic world inside your body where tiny, single-celled invaders are trying to set up camp. These invaders are called Leishmania, and they are the culprits behind a disease called leishmaniasis. To survive, these parasites have to be incredibly clever chemists. They live in two very different neighborhoods: first, inside a sandfly's gut, and later, deep inside the cells of mammals (like you or me). In each neighborhood, the rules of the game change. Inside your cells, the environment is acidic, crowded, and full of "chemical weapons" (oxidative stress) that your immune system throws at them to kill the invaders.
To fight back, the parasites need a steady supply of energy and a way to neutralize those chemical weapons. This is where a special group of molecules called "pyridine nucleotides" comes in. Think of these as the parasite's battery packs and fire extinguishers combined. Some versions of these batteries (NADPH) help build new parts, while others (NAD+) keep the engine running. If the parasite runs out of these batteries or if its fire extinguishers fail, it gets overwhelmed and dies. Scientists have long known that parasites use a specific type of enzyme, called a "malic enzyme," to help manage these batteries. However, until now, we only knew about one version of this enzyme in Leishmania, and we thought it lived in the parasite's power plant (the mitochondria). The big question was: does the parasite have a secret backup plan, or a second tool hidden somewhere else in its body to keep its batteries charged?
This paper tells the story of scientists who found that secret backup plan. They discovered a second version of the malic enzyme, which they named LmME2, and it turns out to be hiding in the main living room of the cell (the cytosol), not the power plant. Here is what they found:
The Discovery of the Cytoplasmic Spy
The researchers started by looking at the parasite's instruction manual (its genome) and realized there were actually two genes for this enzyme, not just one. They confirmed that the second gene, LmME2, is indeed active in both stages of the parasite's life. Using a clever tagging system, they watched the enzyme move around and saw that it lives in the cytosol, the jelly-like fluid that fills the cell. This was a surprise because the other version, LmME1, lives in the mitochondria. It's like finding out a house has two different kinds of electricians: one working in the basement generator room and another working in the main hallway.
The Two-Way Street
When the scientists purified the LmME2 enzyme and tested it in a lab dish, they found it was a versatile worker. It could run a chemical reaction in two directions: turning a molecule called malate into pyruvate (releasing energy), or turning pyruvate back into malate (storing energy). In a test tube, it did both jobs at similar speeds. However, when they looked at the enzyme working inside the actual parasite, it seemed to prefer turning pyruvate back into malate. Why? Because the parasite's internal environment is full of other chemicals that act like traffic cops. The researchers found that molecules like ATP (the cell's energy currency), oxaloacetate, and fumarate act as regulators. They can slow down or speed up the enzyme depending on what the cell needs. It's like a smart thermostat that adjusts the heating based on how cold the room feels.
The Battery Crisis
To figure out what LmME2 actually does for the parasite, the scientists used a genetic "eraser" (CRISPR-Cas9) to delete the LmME2 gene. They created a strain of parasites that had no LmME2 at all. At first, these mutant parasites looked normal and grew just fine in a petri dish. But when the scientists checked their internal batteries, they found a disaster. The mutant parasites had lost a huge chunk of their "oxidized" batteries (NAD+ and NADP+). Interestingly, the "charged" batteries (NADH and NADPH) stayed mostly the same. This suggests that LmME2 isn't just making new energy; it's crucial for recycling the old batteries so the cell doesn't run out of raw materials. Without LmME2, the parasite's battery recycling system breaks down.
The Fire and the Failure
Because the battery system was broken, the mutant parasites couldn't handle stress. When the scientists exposed them to hydrogen peroxide (a chemical weapon similar to what immune cells use), the mutant parasites accumulated dangerous levels of "reactive oxygen species" (ROS)—basically, internal rust and fire. They were also much more sensitive to drugs that blocked their other main way of making batteries (the pentose phosphate pathway).
The real test came when they put these mutant parasites into a living host. When the scientists infected mice with the LmME2-free parasites, the mice barely got sick. The parasites couldn't survive inside the mouse's immune cells (macrophages) and failed to cause the large, painful sores that usually appear. In fact, the number of parasites in the mice was about 100 times lower than in mice infected with normal parasites.
The Conclusion
The paper concludes that LmME2 is a vital, previously unknown guardian of the parasite's health. It acts as a cytosolic malic enzyme that keeps the parasite's battery levels balanced and its internal fire under control. Without it, the parasite is too weak to survive the harsh environment inside a mammal. This discovery suggests that if we can design a drug to specifically block LmME2, we might be able to starve the parasite of its redox balance and stop the disease, all without hurting the human host, since our version of this enzyme works differently. The scientists have identified a new, promising target for fighting leishmaniasis.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.